Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 7/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24342186 | 0.85 | GAA (0.47) | GAAMAPTSMN1; SMN2LMNATP53 | |
| SCHEMBL25569654 | 0.80 | GRIA2 (0.43) | GAAMAPTALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL12100575 | 0.78 | DRD2 (0.37) | GAAMAPTALDH1A1KDM4EHPGD | |
| SCHEMBL17754706 | 0.77 | GAA (0.42) | GAAMAPTALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL15576782 | 0.77 | SMN1; SMN2 (0.38) | GAAMAPTALDH1A1KDM4EHPGD | |
| SCHEMBL16728722 | 0.77 | GAA (0.40) | GAAMAPTALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL22313607 | 0.75 | GAA (0.43) | GAAMAPTSMN1; SMN2LMNATP53 | |
| SCHEMBL20201470 | 0.75 | GAA (0.46) | GAAMAPTALDH1A1KDM4EHPGD | |
| SCHEMBL26350318 | 0.75 | GAA (0.40) | GAAMAPTALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL20201466 | 0.75 | GAA (0.49) | GAAMAPTSMN1; SMN2LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9773986-B2 | Copper(I)-carbene complexes and organic electroluminescent devices | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2017-09-26 | — | — | US | disclosed |
| US-9773986-B2 | Copper(I)-carbene complexes and organic electroluminescent devices | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2017-09-26 | — | — | US | disclosed |
| EP-2501707-B1 | 3-COORDINATE COPPER (I) - CARBENE COMPLEXES | UNIV SOUTHERN CALIFORNIA (US) | 2017-08-02 | — | — | EP | disclosed |
| US-20140125221-A1 | 3-COORDINATE COPPER(I)-CARBENE COMPLEXES | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2014-05-08 | — | — | US | disclosed |
| US-20140125221-A1 | 3-COORDINATE COPPER(I)-CARBENE COMPLEXES | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2014-05-08 | — | — | US | disclosed |
| US-8580394-B2 | 3-coordinate copper(I)-carbene complexes | UNIVERSAL DISPLAY CORPORATION (US) | 2013-11-12 | — | — | US | disclosed |
| US-8580394-B2 | 3-coordinate copper(I)-carbene complexes | UNIVERSAL DISPLAY CORPORATION (US) | 2013-11-12 | — | — | US | disclosed |
| US-20120056529-A1 | 3-COORDINATE COPPER(I)-CARBENE COMPLEXES | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2012-03-08 | — | — | US | disclosed |
| WO-2011063083-A1 | 3-COORDINATE COPPER (I) - CARBENE COMPLEXES | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2011-05-26 | — | — | WO | disclosed |
| US-20100104985-A1 | COMPOUND FOR PHOTORESIST, PHOTORESIST LIQUID, AND ETCHING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120056529-A1 | 3-COORDINATE COPPER(I)-CARBENE COMPLEXES | AOC3, AOC2, OCIAD1 | GAA 3060/4885MAPT 1967/4885ALDH1A1 774/4885 |
| US-20100104985-A1 | COMPOUND FOR PHOTORESIST, PHOTORESIST LIQUID, AND ETCHING METHOD USING THE SAME | PYCR1, STK10, STK4 | GAA 4323/4885MAPT 264/4885ALDH1A1 3885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.